2006 Workshop Sessions

The Workshop Sessions / Hot Topics / Poster Author Session address the issues and challenges of opioid treatment. These sessions also provide information on how to develop and / or enhance the skills for practitioners providing treatment and the adoption of evidence-based practices within opioid treatment.

Workshops will offer participants a chance to review the latest treatment data and health care policies, examine their implications for our patients, and strengthen the skills needed to improve the quality of services.

BASIC TRACK: This year we will be offering a special sequence of workshops (A1, BI, C1, D1, E1 and F1), designed to act as a refresher for seasoned professionals and to meet the needs of individuals who are new to this field. Those who attend all six sessions listed will receive a special certificate of completion.

 

WORKSHOP SESSIONS
Monday, April, 24, 2006
TIME: 10:30 AM – 12:00 NOON

A – 1  The History of Narcotic Control Policy and the Treatment of Opioid Dependence: Old Lessons for New Practitioners and Patients
Sarah Rockwell Podolin, LSW, MATER-Thomas Jefferson University, Philadelphia, PA
The history of narcotic use and control in America will be examined. Social, professional and political forces that influenced narcotic control policy and treatment will be identified and lessons of the past will be applied to the current climate in which narcotic control policy and treatment is developed and conducted.

A – 2 Methadone Maintenance Treatment and Reentry for Prisoners
Timothy W. Kinlock, PhD, Friends Research Institute, Inc., Baltimore, MD; Terrence T. Fitzgerald, MD, Man Alive, Inc., Baltimore, MD; Gary Sweeney, CACAD, Man Alive, Inc., Baltimore, MD
This workshop will describe the preliminary results of a randomized clinical trial studying the effectiveness of initiating inmates with histories of heroin addiction on methadone maintenance treatment as they near release and continuing in the community. The practical medical and counseling aspects of program implementation will also be presented.

A – 3  Benzodiazepine Use in Opiate Dependent Populations
Robert L. Walsh, BS, National Institute of Health, Bethesda, MD; Joseph Gregory Liberto, MD, Baltimore, VA Medical Center, Baltimore, MD; Richard Steven Schottenfeld, Yale University, New Haven, CT
Many patients who present for opiate treatment also abuse benzodiazepines, which are commonly involved in deaths related to misuse/abuse. This highly interactive workshop will discuss the nature and extent of benzodiazepine abuse, how it affects treatment outcomes in opiate dependent individuals who abuse benzodiazepines and the current treatments for benzodiazepine abuse.

A – 4  A Harm Reduction Approach to Retaining Challenging Populations in Opioid Treatment
Basha Closic, BA, Brandywine Counseling, Inc., Wilmington, DE; Jeremy Zane, BA, Brandywine Counseling, Inc., James Harrison, MHS, Brandywine Counseling, Inc., Wilmington, DE
Continued illicit drug use, in many OTPs, results in disciplinary action, including discharge. A modification of ‘Safety Counts’ attempts to improve these patients’ success. Information on the intensive interventions aimed at reducing harmful or risky behavior, the program’s benefits, necessary resources and interaction with the larger treatment program will be presented.

A – 5 Pervasively Communicating Research and Policy Recommendations to Key Local, State and Federal Decision Makers
John T. Carnevale, PhD, Carnevale Associates, LLC, Darnestown, MD; Jennifer Duncan Collier, JD, Washington, DC
Opioid-based treatment is one of the best researched drug treatments in the world, but government officials and policy makers continue to doubt its effectiveness. This workshop will help researchers and providers learn how to translate research and best practice into practical policy recommendations and effectively communicate these recommendations to decision-makers.

TIME: 1:30 PM – 3:00 PM

The Role of the Nurse in OTPs
Maureen Alves, LPN, Center for Behavioral Health Rhode Island, Johnston, RI; Theresa Steinbacher, LPN, Center for Behavioral Health Indiana, Fort Wayne, IN; Rhonda Holoman, LPN, Center for Behavioral Health Louisiana, Shreveport, LA
This workshop will explore the multifaceted role of the nurse in OTPs. It will address the skills and training needed to assist nurses in their changing responsibilities and discuss the strengths and limitations associated with occupying a dual role of counselor/nurse. Evolving requirements for registered nurse vs licensed practical nurse will also be discussed.

Expanding and Strenghtening Baltimore’s Opioid Treatment Programs
Adam Brickner, BA, Baltimore Substance Abuse Systems, Inc., Baltimore, MD; Elaine Swift, PhD, Baltimore Substance Abuse Systems, Inc., Baltimore, MD; Michael Douglas, MHS, Baltimore Substance Abuse Systems, Inc., Baltimore, MD
This presentation will discuss Baltimore’s heroin problem and provide a history of the creation of its non-profit substance abuse authority then go on to describe “DrugStat” – the OTP performance improvement process launched by that agency. The integration of buprenorphine into OTPs in the Baltimore area will also be discussed.

Developing and Implementing a Pro-Active Media Strategy
Gerald Migliore, Media Consultant, Englewood, NJ
This workshop will provide agency directors and/or designated public relations staff with the ability to develop and implement pro-active media and marketing public relations strategies designed to improve the public’s understanding of opioid dependence and medication assisted treatment.

TIME: 3:30 PM – 5:00 PM
B – 1  Medical Aspects of Methadone: What Counselors Need to Know about the Medication

Judith Martin, MD, 14th Street Clinic, Oakland, CA
This workshop will review the basic elements of opioid agonist treatment, such as dose, side effects and duration of MMT. It will cover pharmacologic aspects such as half-life, receptor site, blood level and rapid metabolizer. It is intended to provide a language to engage the patient who is concerned about his or her medication.

B – 2  OTP Interface with the Criminal Justice System
James Carleton, MS, CODAC Behavioral Healthcare, Cranston, RI
This workshop focuses on the relationship between OTPs and incarcerated population, from the viewpoint of a working, viable program. A series of digital interviews with primary stakeholders explore the dynamics of multi-agency systems, often with superficially competing agendas, working towards a common goal: treatment of incarcerated OTP patient. The working model is thoroughly discussed and illustrated.

B – 3  Opioid Prescription Abuse Among Enrollees in Opioid Treatment Programs
Andrew Rosenblum, PhD, National Development and Research Institutes, New York, NY; Mark Parrino, MPA, American Association for the Treatment of Opioid Dependence, New York, NY; Carleen Maxwell, MPH, American Association for the Treatment of Opioid Dependence, New York, NY
We will report findings from an on-going three-year project on prescription opioid abuse, involving all patients enrolling in > 70 OTPs, representing all regions of the United States. Primary focus will be on patient and regional factors associated with prescription opioid abuse and the implications this has for OTPs.

B – 4  Patient and Provider Groups: Methods and Models
Paul Bowman, CMA, Massachusetts NAMA, North Quincy, MA; Donna Schoen, MCA, Long Island NAMA, New Hyde Park, NY; Sharon P. Dembinski, PNP, Webster, MA
Patient representation and committees are becoming more common. Forms, functions, and goals vary. This workshop, presented by a panel of NAMA advocates, describes operations and successes of three different types of patient committees, including a discussion of factors that make them “work”, especially support by provider staff.

B – 5  Methadone and Overdose Prevention
Randy Seewald, MD, Beth Israel Medical Center, New York, NY; Sharon Stancliff, MD, Harm Reduction Coalition, New York, NY; Sarz Maxwell, MD, Chicago Recovery Alliance, Chicago, IL
Drug users experience morbidity and mortality from accidental drug overdose. Learn how methadone treatment prevents overdose and hear an update on prevention, including overviews of heroin overdose physiology and epidemiology and overdose prevention training (including risk factors, recognition, intervention, and a brief video on naloxone use).

 

WORKSHOP SESSIONS
Tuesday, April 25, 2006
TIME: 10:30 AM – 12:00 NOON

C – 1  Culture Counts: Fostering a Culturally Competent System of Care
Michael Freeman, MS, Connecticut Counseling Centers, Inc., Waterbury, CT; Diane Heyward, MS, Connecticut Counseling Centers, Inc., Waterbury, CT; Nydia Diaz, Connecticut Counseling Centers, Inc., Waterbury, CT
This workshop will explore the process of fostering a culturally competent system of care; provide an overview of the challenges in providing culturally competent and recovery-oriented treatment with limited human and financial resources; and will highlight the evolution of cultural diversity within a methadone maintenance treatment program.

C – 2  The Homeless Mentally Ill Methadone Patient in Rikers Island Jail. Keep NYC Program: A Pilot Project for Housing, Medical and Social Services After Release to the Community
Pat Precin, MS, New York Institute of Technology and Pathways to Housing, Inc., New York, NY; Herman Joseph, PhD, Rockefeller University, New York, NY; Kathleen Coughlin, BA, New York City Department of Corrections, New York, NY
A project addressing community needs of incarcerated homeless mentally ill methadone patients in Rikers Island Jail KEEP will be presented. Topics discussed include planning, cooperation of community agencies to establish the pilot, medical and social problems, treatment and resolution of issues, and initial outcomes.

C – 3  Methadone Maintenance Treatment and Older Adults
Carolyn M. Drennan, MA, Beth Israel Medical Center, New York, NY; Randy Seewald, MD, Beth Israel Medical Center, New York, NY; Patti Juliana, LCSW-R, Beth Israel Medical Center, New York, NY
This presentation reviews the medical, mental/cognitive health, social, financial and legal factors involved with working with older patients in methadone maintenance treatment. Suggestions for future interventions, policy changes and specific programming will be offered, and future research will be discussed. This presentation is intended for drug treatment providers.

C – 4 Building Communication Bridges Between Child Protective Services and Drug Treatment Providers
Hendree Jones, PhD, Johns Hopkins University, Baltimore, MD; Karol Kaltenbach, PhD, Thomas Jefferson University, Philadelphia, PA; Peter Selby, MD, St. Joseph’s Health Center, Toronto, ON
This workshop examines relationships between Child Protective Services (CPS) and drug treatment facilities treating pregnant and post-partum women. Highlights include reviewing conflicting priorities of CPS and treatment, impact of laws on treatment outcomes and tools to educate patients, CPS and drug treatment providers to best facilitate relationships between these entities.

C – 5 Establishing and Strenghtening Ties with the Addiction Recovery Community
Lisa Mojer Torres, JD, Faces & Voices of Recovery, Washington, DC; Patricia Taylor, BA, Faces & Voices of Recovery, Washigton, DC; Alice Diorio, Opiate Dependence Resource Center, Brattleboro, VT
An emerging national recovery movement is building a recovery-oriented continuum of care. This workshop will provide ideas to bring patients information on their rights and engage them with recovery community organizations and recovery advocates (including local, regional and national recovery community organizations, as a support resource during early treatment.

TIME: 1:30 PM – 3:00 PM

D – 1  Using an Evidence-based Program to Treat Stimulant Abusers – The Matrix Model
Jeanne L. Obert, MFT, The Matrix Institute, Los Angeles, CA
This workshop will compare the treatment needs of Cocaine and Methamphetamine abusers in order to determine whether differences need to be taken into account when designing effective treatment interventions for stimulant abusers. The Matrix Model, a structured outpatient treatment protocol that has been proven effective when used with stimulant abusers, will be described in detail.

D – 2   A Public Health Approach to Implementing OTP’s in Correctional Settings
Carmen Albizu Garcia, MD, Center for Investigation and Sociomedical Research, San Juan, PR; Gregory Warren, MBA, Maryland Department of Public Safety and Correctional Services, Baltimore, MD; Victor A. Torano Gonzalez, MD, Puerto Rico Department of Correction & Rehabilitation, San Juan, PR
This workshop will describe how the Maryland Department of Public Safety and the Corrections Administration in Puerto Rico have planned for and implemented methadone treatment in the Baltimore City Detention Center and in a prison in San Juan. The presenters will describe their practical experiences and lessons learned.

D – 3 Integrating Recovery-Oriented Standards of Care into MMTP: Cultivating a Culture of Recovery
Alan Lee Nolan, LCSW, Connecticut Counseling Centers, Inc., Waterbury, CT; Michael Freeman, MS, Connecticut Counseling Centers, Inc., Waterbury, CT; Marshall Rosier, MS, Connecticut Counseling Centers, Inc., Waterbury, CT
This workshop will demonstrate the value of cultivating a person-centered culture of recovery within a MMTP setting. Through the examination of an alternative model, presenters will discuss person-centered recovery alliances and partnerships, facilitating empowerment, and the identification of resources needed for creating a self-directed recovery action plan.

D – 4 Evidence-Based Practices in Opioid Treatment: A Comprehensive Technology Transfer Model
Stephen J. Gumbley, MA, Addiction Technology Transfer Center of New England, Providence, RI; Denise M. Howard, BA, Discovery House, Providence, RI
This workshop will present an overview of the ATTC-NE’s comprehensive model for transferring research to practice. The applicability of the transtheoretical change model to organizations, and its relationship to the implementation process, will be discussed. Participants will have an opportunity to practice the methodology and utilize examples drawn from clinical experiences.

D – 5  When Substance Abuse Affects Others: A Six-Skills Model for Survival and Change
Jan Ligon, PhD, Georgia State University, Atlanta, GA
This session will provide an overview of a simple and straightforward model involving six skills that may be helpful to those who are affected by a substance abuser. Handouts will provide information on the model, materials for use with clients, and an evaluation form to assess effectiveness.

Wednesday, April 26, 2006
TIME: 8:00 AM – 9:30 AM

E – 1 Integrating the Skills and Spirit of Motivational Interviewing
Robert C. Lambert, MA, Connecticut Counseling Centers, Norwalk, CT
This workshop will include a brief conceptual overview of Motivational Interviewing, a review of core principles, and an introduction to specific counseling skills. The presenter will also provide the clinician with a roadmap for the successful integration of the Motivational Interviewing style with their current clinical approach and existing clinical culture where they work.

E – 2  Women in the Middle: How to Collaborate and Negotiate Prison Systems to Provide MAT Care for Opioid Dependent Women (OPW) Behind the Walls
Jeneane Burke, MSN, MATER, Thomas Jefferson University, Philadelphia, PA; Kate Vandegrift, MA, MATER, Thomas Jefferson University Hospital, Philadelphia, PA
This workshop will focus on barriers and solutions in treating incarcerated OPW; the need to partner with all levels of care in providing medically accepted treatment; integrating and developing methods of communication within systems that have individual missions, goals and objectives, and restrictions that present challenges in accomplishing best practice outcomes.

E – 3  Drug Interactions Among Medications for the Treatment of Drug Addiction and for HIV/HCV Infections
Jag H. Khalsa, PhD, National Institute on Drug Abuse, Bethesda, MD; David J. Greenblatt, MD, Tufts University School of Medicine, Boston, MA; Evan D. Kharasch, MD, University of Washington School of Medicine, Seattle, WA
The presenters will discuss the incidence of drug-drug interactions, the mechanisms of these interactions, specific issues of drug-drug interactions when treating with methadone or buprenorphine, as well as with other psychotropic medications, ways of predicting when an interaction may occur, the consequences of an interaction and appropriate interventions when an interaction occurs.
* Sponsored by NIDA

E – 4  How We Measured Costs, Cost-Effectiveness, and Cost-Benefit of OTP Accreditation
Brian T. Yates, PhD, American University, Washington, DC; Danyelle Mannix, BA, American University, Washington, DC; Namratha Swamy, PhD, Northrop-Grumman Health Information Technologies, Rockville, MD
In this workshop, participants will be able to create a Cost – Procedure – Process – Outcome Analysis (CPPOA) model based on both the 1999 NIDA manual for (CPPOA), and the OTP accreditation evaluation for their own OTP. Participants will learn how distinctions between costs, processes, and outcomes can provide a framework for evaluating programs.

E – 5 Attempted Suicide and Accidental Overdose in Methadone Maintenance Patients
Gloria Baciewicz, MD, University of Rochester, Rochester, NY; Mary Ellen Ross, RNC, University of Rochester, Rochester, NY
Overdose and suicide are leading causes of death among treated opiate users. This workshop reviews research on risk factors for suicide and unintentional overdose, presents results of a survey of these behaviors among a local sample of MAT patients, and provides guidance in risk assessment, prevention, and intervention.

TIME: 9:45 AM – 11:15 AM

F – 1  Psychiatric Comorbidity
Joan E. Zweben, PhD, 14th Street Clinic/East Bay Community Recovery Project, Oakland, CA
This workshop will discuss how counselors can help integrate the treatment of psychiatric disorders into the methadone treatment program. We will discuss addictive behavior and coexisting psychiatric problems, barriers to addressing them, how to educate the clients appropriately, how to prioritize treatment tasks, and how to work with physicians around psychotropic medication.

F – 2  Integration of Buprenorphine Treatment in Opioid Treatment Programs
C. Danielle Johnson, MPH, US Department of Health and Human Services, Rockville, MD; Charles W. Walton, MD, Discovery House-Utah, Inc., Salt Lake City, UT; Marian Currens, BSN, Center for Addiction Medicine, Baltimore, MD
Although OTPs are permitted to treat patients with buprenorphine, only a limited number have chosen to adopt this treatment modality. This workshop will explore the advantages and challenges of the use of buprenorphine in the OTP setting. The issues to be covered include cost, stigma, and a variety of clinical issues.

F – 3 Paying it Forward: The Utilization of Contingency Management and Motivational Enhancement Therapy with the Resistant Patient
Michael Gaudet, LICSW, Center for Behavioral Health Rhode Island, Johnston, RI; Rainer Franke, MA, Denver Behavioral Health Center-Downtown, Denver, CO
There are many manifestations of resistance which often result in a tug-of-war between patient and counselor. This workshop will explore ways in which the principle of Motivational Enhancement can be incorporated into the philosophical and practical framework of Contingency Management, and how this will be beneficial to the resistant patient.

F – 4  Optimizing Cardiovascular Health and Safety in Methadone-Maintained Patients
Mori Krantz, MD, University of Colorado Denver Health Medical Center, Denver, CO; John Schmittner, MD, National Institutes of Health, Baltimore, MD
This roundtable workshop will review the dose-related effects of methadone on QTc prolongation, risk of torsades de pointes implied by QTc change, indications for electrocardiography, effect of medications affecting hepatic cytochrome P-450 3A4 enzymes, and strategies to weigh the benefits of methadone against the individual patient’s cardiac risk factors.

F – 5  In the Door / Care in 24: Improving Access and Retention
Janet Bardossi, LCSW, CODA, Inc., Portland, OR; Jeanine Bassett, MA, CODA, Inc., Portland, OR
In 2004, CODA started using Process Improvement Strategies in its methadone services with remarkable success. One recent project helped reduce intake waiting times from days to hours. This presentation will focus on practical examples of implementing rapid cycle change strategies to improve care. Promises to be fun and informative application for practice.

Share This